Clobenzorex Stats & Data

Each 30-mg Asenlix®/Itravil® capsule yields roughly 4-5 mg d-amphetamine after first-pass metabolism; subjective strength is about 1/5-1/6 of an Adderall IR tablet. Peak plasma amphetamine appears 1-4 h post-dose. Elimination half-life for parent + metabolites is highly variable (1-17 h) and is prolonged in alkaline urine. Cardiovascular concerns parallel other amphetamines; case-control data link chronic anorectic use to pulmonary arterial hypertension, so limit weekly use and monitor BP. Urine screens >500 ng/mL 'amphetamine' after clobenzorex will also contain the specific metabolite 4-hydroxy-clobenzorex—confirmatory testing can distinguish therapeutic use from illicit amphetamine. Users emphasise smaller test doses (≤25 mg) due to biphasic profile: a short punchy alertness that dips after 2 h before a shallow, long tail. Split-dosing (e.g., 30 mg a.m. + 15 mg noon) reduces the midday slump. Stay hydrated, supplement magnesium/potassium, and schedule at least 48 h stimulant-free to keep tolerance manageable. Additional harm-reduction: avoid rapid redosing during the first 3 h; maintain hydration and electrolyte intake to offset anorexia/dehydration; avoid overheating and heavy exertion to mitigate hyperthermia risk; expect immunoassay urine tests to read 'amphetamine' after clobenzorex and seek GC/MS confirmation if needed.